N-valproyl glycinamide,
N-valproylglycinamide,
TV 1901,
TV-1901,
Valrocemide,
VPGD cpd,
Valrocemide,
92262-58-3,
N-(2-amino-2-oxoethyl)-2-propylpentanamide,
N-Valproylglycinamide,
TV-1901,
UNII-1C7GO6OW7L,
TV 1901,
N-(carbamoylmethyl)-2-propylpentanamide,
1C7GO6OW7L,
Pentanamide, N-(2-amino-2-oxoethyl)-2-propyl-,
n-(2-n-propylpentanoyl)-glycinamide,
Vpgd cpd,
N-Valproyl glycinamide,
Valrocemide [USAN:INN],
TVP-1901,
Valproyl glycinamide,
Valrocemide,tv 1901,
Valrocemide (USAN/INN),
AC1OCF94,
CHEMBL471638,
SCHEMBL4014030,
Valrocemide (TV1901 VGD)),
DTXSID70238939,
SPD-493,
BCP25525,
ZINC1540787,
7370AJ,
MFCD00870963,
TV1901,
AKOS017548022,
CS-7525,
N-(Carbamoylmethyl)-2-propylvaleramide,
SY028535,
HY-100379,
MFCD00870963 (95%),
D02718,
262V583,
Z1505862723,
Valrocemide [INN],
Valrocemide < Prop INN,
D0XT1M,
C10H20N2O2,
C10-H20-N2-O2,
CID6918293,